StockClub

LEXX

LEXXLexaria Bioscience Corp.$ --
Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 02/28/2026FY2026 Q2
Revenue
0M USD
YoY -88.5%
Operating Income
-1M USD
YoY +47.2%
Net Income
-1M USD
YoY +46.6%
EPS
-0.06$
YoY +60.0%

Revenue

$20,000
FY2024 Q3$380,278
$380,278
Q3
FY2024 Q4$464,278
$464,278
Q4
FY2025 Q1$183,923
$183,923
Q1
FY2025 Q2$357,923
$357,923
Q2
FY2025 Q3$531,923
$531,923
Q3
FY2025 Q4$705,923
$705,923
Q4
FY2026 Q1$0
$0
Q1
FY2026 Q2$20,000
$20,000
Q2
Actual
$-337,923 (-94.4%)

Net Income

$-3M
FY2024 Q3$-3.6M
$-3.6M
Q3
FY2024 Q4$-5.8M
$-5.8M
Q4
FY2025 Q1$-2.7M
$-2.7M
Q1
FY2025 Q2$-5.4M
$-5.4M
Q2
FY2025 Q3$-9.2M
$-9.2M
Q3
FY2025 Q4$-11.9M
$-11.9M
Q4
FY2026 Q1$-1.6M
$-1.6M
Q1
FY2026 Q2$-3M
$-3M
Q2
Actual
+$2.4M (+43.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$314,793
Est:$3.8M
FY2020MISS
$314,793
FY2021MISS
Actual:$722,738
Est:$929,088
FY2021MISS
$722,738
FY2022MISS
Actual:$255,396
Est:$339,000
FY2022MISS
$255,396
FY2023MISS
Actual:$226,208
Est:$317,500
FY2023MISS
$226,208
FY2024MISS
Actual:$464,278
Est:$500,000
FY2024MISS
$464,278
FY2025BEAT
Actual:$705,923
Est:$669,000
FY2025BEAT
$705,923

Analyst Estimates